107 related articles for article (PubMed ID: 25264306)
1. Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland.
McAllister G; Innes H; Mcleod A; Dillon JF; Hayes PC; Fox R; Barclay ST; Templeton K; Aitken C; Gunson R; Goldberg D; Hutchinson SJ
J Clin Virol; 2014 Nov; 61(3):359-64. PubMed ID: 25264306
[TBL] [Abstract][Full Text] [Related]
2. Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.
McDonald SA; Hutchinson SJ; Innes HA; Allen S; Bramley P; Bhattacharyya D; Carman W; Dillon JF; Fox R; Fraser A; Goldberg DJ; Kennedy N; Mills PR; Morris J; Stanley AJ; Wilks D; Hayes PC
J Viral Hepat; 2014 May; 21(5):366-76. PubMed ID: 24716639
[TBL] [Abstract][Full Text] [Related]
3. Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia.
Iversen J; Grebely J; Catlett B; Cunningham P; Dore GJ; Maher L
Int J Drug Policy; 2017 Sep; 47():77-85. PubMed ID: 28578863
[TBL] [Abstract][Full Text] [Related]
4. Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing.
McLeod A; Weir A; Aitken C; Gunson R; Templeton K; Molyneaux P; McIntyre P; McDonald S; Goldberg D; Hutchinson S
J Epidemiol Community Health; 2014 Dec; 68(12):1182-8. PubMed ID: 25170094
[TBL] [Abstract][Full Text] [Related]
5. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
6. Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia.
Saludes V; Antuori A; Folch C; González N; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
Int J Drug Policy; 2019 Dec; 74():236-245. PubMed ID: 31706159
[TBL] [Abstract][Full Text] [Related]
7. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
[TBL] [Abstract][Full Text] [Related]
8. Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre.
Islam MM; Topp L; Conigrave KM; White A; Reid SE; Grummett S; Haber PS; Day CA
J Subst Abuse Treat; 2012 Dec; 43(4):440-5. PubMed ID: 22938915
[TBL] [Abstract][Full Text] [Related]
9. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial.
Hickman M; McDonald T; Judd A; Nichols T; Hope V; Skidmore S; Parry JV
J Viral Hepat; 2008 Apr; 15(4):250-4. PubMed ID: 18086182
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
[TBL] [Abstract][Full Text] [Related]
11. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
[TBL] [Abstract][Full Text] [Related]
12. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
[TBL] [Abstract][Full Text] [Related]
13. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.
Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous detection of hepatitis C virus antigen and antibodies in dried blood spots.
Brandão CP; Marques BL; Marques VA; Villela-Nogueira CA; Do Ó KM; de Paula MT; Lewis-Ximenez LL; Lampe E; Sá Ferreira JA; Villar LM
J Clin Virol; 2013 Jun; 57(2):98-102. PubMed ID: 23518440
[TBL] [Abstract][Full Text] [Related]
15. Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review.
Bajis S; Dore GJ; Hajarizadeh B; Cunningham EB; Maher L; Grebely J
Int J Drug Policy; 2017 Sep; 47():34-46. PubMed ID: 28797498
[TBL] [Abstract][Full Text] [Related]
16. Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service.
Craine N; Parry J; O'Toole J; D'Arcy S; Lyons M
J Viral Hepat; 2009 Mar; 16(3):219-22. PubMed ID: 19175879
[TBL] [Abstract][Full Text] [Related]
17. Dried blood spot for hepatitis C virus serology and molecular testing.
Tuaillon E; Mondain AM; Meroueh F; Ottomani L; Picot MC; Nagot N; Van de Perre P; Ducos J
Hepatology; 2010 Mar; 51(3):752-8. PubMed ID: 20043287
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.
Charlebois A; Lee L; Cooper E; Mason K; Powis J
J Viral Hepat; 2012 Dec; 19(12):836-42. PubMed ID: 23121361
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots.
Judd A; Parry J; Hickman M; McDonald T; Jordan L; Lewis K; Contreras M; Dusheiko G; Foster G; Gill N; Kemp K; Main J; Murray-Lyon I; Nelson M
J Med Virol; 2003 Sep; 71(1):49-55. PubMed ID: 12858408
[TBL] [Abstract][Full Text] [Related]
20. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.
Palmateer N; Hutchinson S; McAllister G; Munro A; Cameron S; Goldberg D; Taylor A
J Viral Hepat; 2014 Jan; 21(1):25-32. PubMed ID: 24329854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
